Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance

Nature Communications

Volumn 5, Issue , 2014, Pages

  De Almeida, Patricia E ^a   Meyer, Everett H ^a   Kooreman, Nigel G ^a   Diecke, Sebastian ^a   Dey, Devaveena ^a   Sanchez Freire, Veronica ^a   Hu, Shijun ^a   Ebert, Antje ^a   Odegaard, Justin ^a   Mordwinkin, Nicholas M ^a   Brouwer, Thomas P ^a   Lo, David ^a,b   Montoro, Daniel T ^a,b   Longaker, Michael T ^a,b   Negrin, Robert S ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; PERFORIN; GRANZYME;

ANTIGEN; CLONE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC STRUCTURE; GENETIC VARIATION; IMMUNE RESPONSE; STATISTICAL ANALYSIS;

ANTIGEN EXPRESSION; AORTIC ENDOTHELIAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; ENDOTHELIUM CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SOMATIC CELL; ANIMAL; AORTA; CELL CULTURE; CYTOLOGY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; INDUCED PLURIPOTENT STEM CELL; MOUSE; TRANSPLANTATION;

ANIMALS; AORTA; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GRAFT REJECTION; GRAFT SURVIVAL; GRANZYMES; IMMUNE TOLERANCE; INDUCED PLURIPOTENT STEM CELLS; INTERLEUKIN-10; MICE; PERFORIN; SELF TOLERANCE;

EID: 84901760609     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4903     Document Type: Article

References (48)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
3. Zhao, T., Zhang, Z. N., Rong, Z. & Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215 (2011).
4. Boyd, A. S. & Wood, K. J. Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS ONE 5, e10965 (2010).
5. Nicholls, S. et al. Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. Proc. Natl Acad. Sci. USA 106, 3889-3894 (2009).
6. Mullally, A. & Ritz, J. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 109, 1355-1362 (2007). (Pubitemid 46239565)
7. Ben-David, U., Nudel, N. & Benvenisty, N. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat. Commun. 4, 1992 (2013).
8. Jia, F. et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7, 197-199 (2010).
9. Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-1181 (2007). (Pubitemid 47538112)
10. Li, Z. et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116, 146-154 (2007).
11. Han, Y. M., Guo, Q. L., Zhang, M. G., Chen, Z. B. & Cao, X. T. CD69()CD4()CD25(-) T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta. J. Immunol. 182, 111-120 (2009).
12. Wang, T. et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10, 48-54 (2004). (Pubitemid 38524698)
13. Welte, T. et al. STAT3 deletion during hematopoiesis causes Crohn's diseaselike pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl Acad. Sci. USA 100, 1879-1884 (2003). (Pubitemid 36254542)
14. Kortylewski, M. et al. Inhibiting STAT3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 11, 1314-1321 (2005). (Pubitemid 41752912)
15. Peppa, D. et al. Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J. Exp. Med. 210, 99-114 (2013).
16. Zhang, Y., Feng, X. H. & Derynck, R. Smad3 and Smad4 cooperate with c-Jun/ c-Fos to mediate TGF-beta-induced transcription. Nature 394, 909-913 (1998). (Pubitemid 28410915)
17. Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008).
18. Le Texier, L. et al. Immunoregulatory function of IL-27 and TGF-beta1 in cardiac allograft transplantation. Transplantation 94, 226-233 (2012).
19. Schietinger, A., Delrow, J. J., Basom, R. S., Blattman, J. N. & Greenberg, P. D. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science 335, 723-727 (2012).
20. Narsinh, K. H. et al. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J. Clin. Invest. 121, 1217-1221 (2011).
21. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007). (Pubitemid 46919862)
22. Perez, V. L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417 (1997). (Pubitemid 27208196)
23. Keir, M. E., Butte, M. J., Freeman, G. J. & Sharpe, A. H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704 (2008). (Pubitemid 351600389)
24. Nurieva, R. I. et al. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. Immunity 32, 670-680 (2010).
25. Shembade, N. et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9, 254-262 (2008). (Pubitemid 351276830)
26. Zilberberg, J., McElhaugh, D., Gichuru, L. N., Korngold, R. & Friedman, T. M. Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vbeta spectratype analysis. J. Immunol. 180, 5352-5359 (2008).
27. Gagne, K. et al. Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts. J. Immunol. 164, 1553-1563 (2000). (Pubitemid 30067273)
28. Guillet, M. et al. Different qualitative and quantitative regulation of V beta TCR transcripts during early acute allograft rejection and tolerance induction. J. Immunol. 168, 5088-5095 (2002). (Pubitemid 34495972)
29. Dietrich, P. Y. et al. Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood 80, 2419-2424 (1992).
30. Matsutani, T. et al. Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation. Br. J. Haematol. 109, 759-769 (2000). (Pubitemid 30609753)
31. Bhattacharya, A. On a measure of divergence between two statistical populations defined by their probability distribution. Sankhya% Indian J. Statist. 7, 401-406 (1943).
32. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290 (2010).
33. Bar-Nur, O., Russ, H. A., Efrat, S. & Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9, 17-23 (2011).
34. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
35. Cunningham, J. J., Ulbright, T. M., Pera, M. F. & Looijenga, L. H. Lessons from human teratomas to guide development of safe stem cell therapies. Nat. Biotechnol. 30, 849-857 (2012).
36. Araki, R. et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494, 100-104 (2013).
37. Guha, P., Morgan, J. W., Mostoslavsky, G., Rodrigues, N. P. & Boyd, A. S. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12, 407-412 (2013).
38. Sun, B., Chen, M., Hawks, C. L., Pereira-Smith, O. M. & Hornsby, P. J. The minimal set of genetic alterations required for conversion of primary human fibroblasts to cancer cells in the subrenal capsule assay. Neoplasia 7, 585-593 (2005). (Pubitemid 40967759)
39. Woo, E. Y. et al. Regulatory CD4()CD25() T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61, 4766-4772 (2001). (Pubitemid 32691889)
40. Blank, C. et al. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8 T cells. Cancer Res. 64, 1140-1145 (2004). (Pubitemid 38176921)
41. Baitsch, L. et al. Exhaustion of tumor-specific CD8() T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350-2360 (2011).
42. Walker, L. S. K. & Abbas, A. K. The enemy within: Keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2, 11-19 (2002). (Pubitemid 37328771)
43. Kohyama, M. et al. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc. Natl Acad. Sci. USA 101, 4192-4197 (2004). (Pubitemid 38405905)
44. Akkaraju, S. et al. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7, 255-271 (1997). (Pubitemid 27392017)
45. Batsford, S. et al. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful? Clin. Nephrol. 75, 101-106 (2011).
46. Miyao, T. et al. Plasticity of Foxp3() T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262-275 (2012).
47. Carlson, C. S. et al. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 4, 2680 (2013).
48. Meyer, E. H. et al. A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease. Blood 121, 4955-4962 (2013).